Tirzepatide
- All
- News
-
Tirzepatide And Semaglutide: Experts Explain New Diabetes, Obesity Drug Options
With semaglutide's patent expiry in India, cheaper generics may expand access to obesity and diabetes care. Experts weigh benefits, risks, and how tirzepatide compares as a next-generation dual-action therapy.
-
Tanmay Bhat Says He Had No Hunger Suppression While On Weight Loss Drugs; Here's Why
While GLP-1 medications are highly effective for many, an estimated 13% to 25% of users may be considered non-responders who do not experience desired appetite suppression or weight loss.
-
Tanmay Bhat Admits To Using Weight Loss Drugs: Why It Isn't Working For Him
GLP-1 drugs are highly effective, FDA-approved medications for managing type 2 diabetes
-
Novo Nordisk's CagriSema Delivers 23% Weight Loss In Trial But Still Trails Eli Lilly's Tirzepatide
CagriSema is a once-weekly subcutaneous injection, which is being investigated by Novo Nordisk as a treatment for adults with overweight or obesity.
-
10 Common Side Effects Of Mounjaro, Ozempic And How To Handle Them, As Per An Apollo Doctor
From dry mouth and fatigue to nausea and weight regain, an expert breaks down 10 common side effects of weight-loss drugs and how to deal with them
-
Aishwarya Mohanraj Says She Used Mounjaro For 22 Kg Weight Loss: Doctor Explains How It Works And Who Should Avoid It
Mounjaro, a diabetes and weight-loss drug, is the brand name for tirzepatide. It is a prescription drug primarily used for type-2 diabetes. The drug is also widely used for its weight loss benefits.
-
WHO Adds Key Diabetes, Weight-Loss Drugs To Essential Medicines List
The World Health Organization has added key GLP-1 drugs, semaglutide and tirzepatide, to its Essential Medicines List for type 2 diabetes with obesity or comorbidities.
-
WHO Backs Weight-Loss Drugs To Treat Diabetes, Obesity, Urges Cheap Generics
The World Health Organization recommended a range of blockbuster weight-loss drugs to treat diabetes and obesity globally for the first time on Friday, calling for cheap generic versions to be made available for people in developing countries.
-
Obesity Injections May Have Fewer Weight Loss Effects In Real World: Study
Anti-obesity injections may have smaller effects on weight loss in a real-world context compared to clinical trials, as patients tend to discontinue treatment or use a lower maintenance dose, a study in US patients has found.
-
Eli Lilly Launches Weight Loss Drug In India: What You Should Know About Mounjaro
Mounjaro for Weight Loss: By influencing multiple body systems simultaneously, tirzepatide offers a powerful approach to managing both diabetes and weight.
-
Tirzepatide And Semaglutide: Experts Explain New Diabetes, Obesity Drug Options
With semaglutide's patent expiry in India, cheaper generics may expand access to obesity and diabetes care. Experts weigh benefits, risks, and how tirzepatide compares as a next-generation dual-action therapy.
-
Tanmay Bhat Says He Had No Hunger Suppression While On Weight Loss Drugs; Here's Why
While GLP-1 medications are highly effective for many, an estimated 13% to 25% of users may be considered non-responders who do not experience desired appetite suppression or weight loss.
-
Tanmay Bhat Admits To Using Weight Loss Drugs: Why It Isn't Working For Him
GLP-1 drugs are highly effective, FDA-approved medications for managing type 2 diabetes
-
Novo Nordisk's CagriSema Delivers 23% Weight Loss In Trial But Still Trails Eli Lilly's Tirzepatide
CagriSema is a once-weekly subcutaneous injection, which is being investigated by Novo Nordisk as a treatment for adults with overweight or obesity.
-
10 Common Side Effects Of Mounjaro, Ozempic And How To Handle Them, As Per An Apollo Doctor
From dry mouth and fatigue to nausea and weight regain, an expert breaks down 10 common side effects of weight-loss drugs and how to deal with them
-
Aishwarya Mohanraj Says She Used Mounjaro For 22 Kg Weight Loss: Doctor Explains How It Works And Who Should Avoid It
Mounjaro, a diabetes and weight-loss drug, is the brand name for tirzepatide. It is a prescription drug primarily used for type-2 diabetes. The drug is also widely used for its weight loss benefits.
-
WHO Adds Key Diabetes, Weight-Loss Drugs To Essential Medicines List
The World Health Organization has added key GLP-1 drugs, semaglutide and tirzepatide, to its Essential Medicines List for type 2 diabetes with obesity or comorbidities.
-
WHO Backs Weight-Loss Drugs To Treat Diabetes, Obesity, Urges Cheap Generics
The World Health Organization recommended a range of blockbuster weight-loss drugs to treat diabetes and obesity globally for the first time on Friday, calling for cheap generic versions to be made available for people in developing countries.
-
Obesity Injections May Have Fewer Weight Loss Effects In Real World: Study
Anti-obesity injections may have smaller effects on weight loss in a real-world context compared to clinical trials, as patients tend to discontinue treatment or use a lower maintenance dose, a study in US patients has found.
-
Eli Lilly Launches Weight Loss Drug In India: What You Should Know About Mounjaro
Mounjaro for Weight Loss: By influencing multiple body systems simultaneously, tirzepatide offers a powerful approach to managing both diabetes and weight.
